Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture.
Schwartz
Michal
M
Weizmann Institute of Science, Rehovot, Israel. michal.schwartz@weizmann.ac.il
D000818:Animals; D001323:Autoantibodies / Q000097:blood; D001324:Autoantigens / Q000276:immunology; D001363:Awards and Prizes; D005431:Florida; D005901:Glaucoma / Q000276:immunology / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D009410:Nerve Degeneration / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D009416:Nerve Regeneration / Q000502:physiology; D018696:Neuroprotective Agents / Q000276:immunology / Q000627:therapeutic use*; D009885:Ophthalmology; D009900:Optic Nerve / Q000502:physiology; D009901:Optic Nerve Diseases / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D010455:Peptides / Q000276:immunology; D012958:Societies, Scientific; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014612:Vaccines / Q000627:therapeutic use*
D001323:Autoantibodies; D001324:Autoantigens; D018696:Neuroprotective Agents; D010455:Peptides; D014612:Vaccines; C021759:(T,G)-A-L